Loading

FDA Fireside Chat

October 23, 2026
Grand Ballroom
Type: Keynote
Join us for a moderated discussion between BIO CEO John Crowley and Dr. Mike Davis, Director of the Center for Drug Evaluation and Research (CDER) and Karim Mikhail, Director of the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA). Topics will include center priorities, patient engagement, and FDA in the next one, five, and twenty years.
Moderator
John F. Crowley
President and CEO
Biotechnology Innovation Organization (BIO)
Speakers
Michael Davis, MD, PhD
Center Director, Center for Drug Evaluation and Research (CDER)
U.S. Food and Drug Administration (FDA)
Karim Mikhail, B.Pharm, MSc
Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (FDA)